We are live on !
Find out more
1492 Capital Management Portfolio holdings
AUM
$339M
Turnover
16.08%
1-Year Est. Return
120.53%
This Fund
S&P 500
This Quarter Est. Return
+67.38%
1 Year Est. Return
+120.53%
3 Year Est. Return
+331.5%
5 Year Est. Return
+431.82%
10 Year Est. Return
+4,350.35%
AUM
$339M
AUM Growth
+$76.1M
(+29%)
Cap. Flow
-$23.3M
Cap. Flow % of AUM
Cap. Flow %
-6.88%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
143
New
13
Increased
21
Reduced
79
Closed
10
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lantheus
LNTH
|
+$3.54M |
| 2 |
Alignment Healthcare
ALHC
|
+$3.14M |
| 3 |
SGHC Ltd
SGHC
|
+$2.68M |
| 4 |
New Era Energy & Digital Inc
NUAI
|
+$2.41M |
| 5 |
Axsome Therapeutics
AXSM
|
+$2.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MaxLinear
MXL
|
+$12.8M |
| 2 |
Applied Optoelectronics
AAOI
|
+$7.92M |
| 3 |
Permian Resources
PR
|
+$3.7M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$2.9M |
| 5 |
NPK International
NPKI
|
+$2.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.02% |
| 2 | Healthcare | 20.7% |
| 3 | Industrials | 18.36% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Financials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
MaxLinear
MXL
$6.31B
| $17.4M | 5.15% |
136,174
-180,650
| -57% | -$12.8M |
2024 Q4
6 quarters
|
|
2
Carpenter Technology
CRS
$14.3B
| $16.9M | 4.99% |
27,425
-1,750
| -6% | -$824K |
2022 Q1
17 quarters
|
|
|
3
Alignment Healthcare
ALHC
$1.66B
| $11.6M | 3.43% |
487,369
+163,350
| +50% | +$3.14M |
2024 Q3
7 quarters
|
|
|
4
Applied Optoelectronics
AAOI
$6.22B
| $11.3M | 3.34% |
76,405
-48,731
| -39% | -$7.92M |
2025 Q4
2 quarters
|
|
5
Sterling Infrastructure
STRL
$11.1B
| $9.12M | 2.69% |
10,863
-863
| -7% | -$606K |
2023 Q3
11 quarters
|
|
6
Copa Holdings
CPA
$5.34B
| $8.95M | 2.64% |
57,508
+3,765
| +7% | +$490K |
2020 Q3
23 quarters
|
|
7
Adaptive Biotechnologies
ADPT
$4.23B
| $8.21M | 2.42% |
382,840
+101,744
| +36% | +$1.56M |
2025 Q4
2 quarters
|
|
8
ATI
ATI
$22.6B
| $8.09M | 2.39% |
41,060
-805
| -2% | -$136K |
2024 Q3
7 quarters
|
|
9
Adtran
ADTN
$536M
| $7.97M | 2.35% |
573,128
-51,896
| -8% | -$810K |
2024 Q4
6 quarters
|
|
10
Kaiser Aluminum
KALU
$1.79B
| $7.63M | 2.25% |
38,985
-4,476
| -10% | -$761K |
2025 Q2
4 quarters
|
|
11
Lumentum
LITE
$75.5B
| $7.59M | 2.24% |
8,841
-147
| -2% | -$131K |
2025 Q2
4 quarters
|
|
12
Zeta Global
ZETA
$8.38B
| $7.5M | 2.21% |
381,000
-29,257
| -7% | -$543K |
2022 Q2
16 quarters
|
|
|
13
Lantheus
LNTH
$6.54B
| $7.26M | 2.14% |
65,439
+38,015
| +139% | +$3.54M |
2026 Q1
1 quarter
|
|
|
14
Axsome Therapeutics
AXSM
$7.54B
| $7.17M | 2.12% |
29,307
+10,713
| +58% | +$2.32M |
2025 Q2
4 quarters
|
|
15
Meritage Homes
MTH
$4.09B
| $7.06M | 2.08% |
84,158
-6,932
| -8% | -$473K |
2025 Q1
5 quarters
|
|
16
Third Coast Bancshares
TCBX
$672M
| $7.04M | 2.08% |
174,205
+41,443
| +31% | +$1.62M |
2024 Q4
6 quarters
|
|
17
Jefferies Financial Group
JEF
$10.6B
| $6.83M | 2.02% |
136,701
+28,928
| +27% | +$1.49M |
2023 Q3
11 quarters
|
|
18
Astrana Health
ASTH
$1.87B
| $6.77M | 2% |
145,946
-7,754
| -5% | -$279K |
2025 Q4
2 quarters
|
|
19
IMAX
IMAX
$2.86B
| $6.06M | 1.79% |
152,146
-9,961
| -6% | -$382K |
2024 Q2
8 quarters
|
|
20
Magnite
MGNI
$3.13B
| $6.03M | 1.78% |
317,750
-22,792
| -7% | -$327K |
2023 Q4
10 quarters
|
|
21
Ichor Holdings
ICHR
$1.45B
| $5.24M | 1.55% |
46,655
-15,977
| -26% | -$1.15M |
2026 Q1
1 quarter
|
|
22
Stifel
SF
$10B
| $5.2M | 1.54% |
74,579
-6,340
| -8% | -$473K |
2023 Q1
13 quarters
|
|
23
Kura Oncology
KURA
$850M
| $5.12M | 1.51% |
467,153
-18,970
| -4% | -$179K |
2022 Q2
16 quarters
|
|
24
HealthEquity
HQY
$8.49B
| $4.65M | 1.37% |
51,501
-4,271
| -8% | -$362K |
2024 Q3
7 quarters
|
|
25
Granite Construction
GVA
$4.84B
| $4.53M | 1.34% |
28,645
-3,627
| -11% | -$493K |
2022 Q3
15 quarters
|
|
Similar funds
FC
ODFS
1492 Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, 1492 Capital Management held 143 positions worth $339M, up 29% from $263M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
1492 Capital Management withdrew a net $23.3M in Q2 2026, closing 10 positions and reducing 79 holdings. Its most notable exit was Permian Resources, an estimated $3.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 1492 Capital Management opened a new position in SGHC Ltd worth $2.87M.
- 1492 Capital Management's largest Q2 2026 buy was SGHC Ltd: 211,740 shares worth $2.87M.
- 1492 Capital Management added most to Lantheus in Q2 2026, an estimated $3.54M increase.
- 1492 Capital Management's biggest Q2 2026 reduction was MaxLinear, cutting an estimated $12.8M.
- 1492 Capital Management fully exited Permian Resources in Q2 2026, selling an estimated $3.7M.
- 1492 Capital Management's ten largest holdings make up 32% of its $339M portfolio in Q2 2026.
- 1492 Capital Management opened 13 new positions and closed 10 in Q2 2026.
- 1492 Capital Management's portfolio value rose 29% quarter-over-quarter to $339M.
Based on 1492 Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.